Viewing nowAtorvastatin Calcium Hydrate 10 mg Tablet
Atorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

MFDS item code 201307559 · Approved 2013.05.30 · Insurance code 650303020
Improvement of hyperlipidemia (e.g., hypercholesterolemia); prevention of cardiovascular diseases (e.g., myocardial infarction)
This medication helps reduce the risk of cardiovascular diseases. It particularly decreases the risk of myocardial infarction and stroke, as well as the risk of vascular surgery and angina. Additionally, it is effective in lowering total cholesterol and LDL cholesterol while increasing good HDL cholesterol in patients with hyperlipidemia. This drug is also used for patients with familial hypercholesterolemia that are not controlled through diet and specific dyslipidemias. It assists in lowering cholesterol levels in pediatric patients with heterozygous familial hypercholesterolemia. Overall, this medication is used to improve cardiovascular health and reduce related risks.
Patients taking or about to take atorvastatin should follow a standard cholesterol-lowering diet. This drug may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring greater reductions in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of more than 45 % is required). This drug is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or use it when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: Efficacy and safety in patients 70 years of age or older are similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on administering doses of this drug higher than 20 mg in pediatric patients).
This medication may cause muscle-related abnormalities; therefore, if muscle pain or weakness worsens, or if creatine kinase levels significantly increase, treatment should be stopped immediately. This drug should not be used in women who are pregnant or have certain diseases, in children under the age of 10, or in patients with severely impaired liver function. Individuals with a history of alcohol abuse or liver disease, those with poor kidney function, and patients with hypothyroidism should use this medication cautiously, and muscle-related tests are recommended beforehand. While taking this medication, side effects such as muscle pain, fatigue, indigestion, headaches, and skin rashes may occur, and patients should consult with their doctor if these symptoms arise. As this medication can affect liver function, regular liver function tests should be performed, and if symptoms of hepatitis or jaundice appear, treatment should be stopped immediately. Women who are pregnant or breastfeeding should not take this medication, and women of childbearing age should use adequate contraception while taking it. This drug has numerous interactions with other medications; caution is needed when taking together with certain antibiotics, antifungal agents, antivirals, some lipid-lowering agents, and grapefruit juice. Elderly patients or those with impaired kidney function are at increased risk of muscle-related side effects, so careful monitoring is required during administration. In case of overdose, there is no specific antidote, so treatment should be symptomatic, and liver function and muscle enzyme levels should be monitored continuously as needed. This medication should be stored out of the reach of children and kept securely in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and the temperature should be between 1 to 30 degrees Celsius, ideally at room temperature. Storing it this way helps maintain the drug's effectiveness and prevents deterioration.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.